Literature DB >> 16629179

Effect of iron on the activation of the MAPK/ERK pathway in PC12 neuroblastoma cells.

Pablo Muñoz1, Gabriela Zavala, Karen Castillo, Pabla Aguirre, Cecilia Hidalgo, Marco T Núñez.   

Abstract

Recent evidence suggests that reactive oxygen species function as second messenger molecules in normal physiological processes. For example, activation of N-Methyl-D-Aspartate receptor results in the production of ROS, which appears to be critical for synaptic plasticity, one of the cellular mechanisms that underlie learning and memory. In this work, we studied the effect of iron in the activation of MAPK/ERK pathway and on Ca2+ signaling in neuronal PC12 cells. We found that iron-dependent generation of hydroxyl radicals is likely to modulate Ca2+ signaling through RyR calcium channel activation, which, in turn, activates the MAPK/ERK pathway. These findings underline the relevance of iron in normal neuronal function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629179     DOI: 10.4067/s0716-97602006000100021

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  26 in total

1.  Hypoxia-Induced Iron Accumulation in Oligodendrocytes Mediates Apoptosis by Eliciting Endoplasmic Reticulum Stress.

Authors:  Gurugirijha Rathnasamy; Madhuvika Murugan; Eng-Ang Ling; Charanjit Kaur
Journal:  Mol Neurobiol       Date:  2015-08-29       Impact factor: 5.590

2.  Serum Iron Protects from Renal Postischemic Injury.

Authors:  Céline Vaugier; Mariane T Amano; Jonathan M Chemouny; Michael Dussiot; Claire Berrou; Marie Matignon; Sanae Ben Mkaddem; Pamella H M Wang; Aurélie Fricot; Thiago T Maciel; Damien Grapton; Jacques R R Mathieu; Carole Beaumont; Marie-Noëlle Peraldi; Carole Peyssonnaux; Laurent Mesnard; Eric Daugas; François Vrtovsnik; Renato C Monteiro; Olivier Hermine; Yelena Z Ginzburg; Marc Benhamou; Niels O S Camara; Martin Flamant; Ivan C Moura
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

Review 3.  Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury.

Authors:  Aric F Logsdon; Brandon P Lucke-Wold; Ryan C Turner; Jason D Huber; Charles L Rosen; James W Simpkins
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

4.  Cardioprotection by Hepc1 in cTnT(R141W) transgenic mice.

Authors:  Li Zhang; Dan Lu; Wei Zhang; Xiongzhi Quan; Wei Dong; Yanfeng Xu; Lianfeng Zhang
Journal:  Transgenic Res       Date:  2011-12-24       Impact factor: 2.788

5.  Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity.

Authors:  Pablo Muñoz; Alexis Humeres; Claudio Elgueta; Alfredo Kirkwood; Cecilia Hidalgo; Marco T Núñez
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 6.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 7.  The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New Developments.

Authors:  Mohammad Rafi Khezri; Keyvan Yousefi; Ayda Esmaeili; Morteza Ghasemnejad-Berenji
Journal:  Cell Mol Neurobiol       Date:  2022-01-17       Impact factor: 5.046

8.  Heme reversibly damps PERIOD2 rhythms in mouse suprachiasmatic nucleus explants.

Authors:  C J Guenthner; D Bickar; M E Harrington
Journal:  Neuroscience       Date:  2009-08-19       Impact factor: 3.590

Review 9.  The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Authors:  Douglas G Peters; James R Connor; Mark D Meadowcroft
Journal:  Neurobiol Dis       Date:  2015-08-22       Impact factor: 5.996

10.  Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.

Authors:  Shalini S Rao; Larissa Lago; Irene Volitakis; Jay J Shukla; Gawain McColl; David I Finkelstein; Paul A Adlard
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.